Search by Drug Name or NDC

    NDC 78206-0118-01 CELESTONE SOLUSPAN 3; 3 mg/mL; mg/mL Details

    CELESTONE SOLUSPAN 3; 3 mg/mL; mg/mL

    CELESTONE SOLUSPAN is a INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Organon LLC. The primary component is BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE.

    Product Information

    NDC 78206-0118
    Product ID 78206-118_501138c6-f3e1-4c97-84e0-ff0e72f5b9a4
    Associated GPIs 22109902101810
    GCN Sequence Number 006758
    GCN Sequence Number Description betamethasone acetate,sod phos VIAL 6 MG/ML INJECTION
    HIC3 P5A
    HIC3 Description GLUCOCORTICOIDS
    GCN 82300
    HICL Sequence Number 002881
    HICL Sequence Number Description BETAMETHASONE ACETATE/BETAMETHASONE SODIUM PHOSPHATE
    Brand/Generic Brand
    Proprietary Name CELESTONE SOLUSPAN
    Proprietary Name Suffix n/a
    Non-Proprietary Name Betamethasone Acetate and Betamethasone Sodium Phosphate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SUSPENSION
    Route INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE
    Active Ingredient Strength 3; 3
    Active Ingredient Units mg/mL; mg/mL
    Substance Name BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
    Labeler Name Organon LLC
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA014602
    Listing Certified Through 2024-12-31

    Package

    NDC 78206-0118-01 (78206011801)

    NDC Package Code 78206-118-01
    Billing NDC 78206011801
    Package 1 VIAL, MULTI-DOSE in 1 BOX (78206-118-01) / 5 mL in 1 VIAL, MULTI-DOSE
    Marketing Start Date 2021-06-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 7.97469
    Pricing Unit ML
    Effective Date 2023-01-16
    NDC Description CELESTONE SOLUSPAN 30 MG/5 ML
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis